title: Analysis of cannabis seizures in NSW, Australia: cannabis potency and cannabinoid profile.
abstract: Recent analysis of the cannabinoid content of cannabis plants suggests a shift towards use of high potency plant material with high levels of Δ(9)-tetrahydrocannabinol (THC) and low levels of other phytocannabinoids, particularly cannabidiol (CBD). Use of this type of cannabis is thought by some to predispose to greater adverse outcomes on mental health and fewer therapeutic benefits. Australia has one of the highest per capita rates of cannabis use in the world yet there has been no previous systematic analysis of the cannabis being used. In the present study we examined the cannabinoid content of 206 cannabis samples that had been confiscated by police from recreational users holding 15 g of cannabis or less, under the New South Wales "Cannabis Cautioning" scheme. A further 26 "Known Provenance" samples were analysed that had been seized by police from larger indoor or outdoor cultivation sites rather than from street level users. An HPLC method was used to determine the content of 9 cannabinoids: THC, CBD, cannabigerol (CBG), and their plant-based carboxylic acid precursors THC-A, CBD-A and CBG-A, as well as cannabichromene (CBC), cannabinol (CBN) and tetrahydrocannabivarin (THC-V). The "Cannabis Cautioning" samples showed high mean THC content (THC+THC-A = 14.88%) and low mean CBD content (CBD+CBD-A = 0.14%). A modest level of CBG was detected (CBG+CBG-A = 1.18%) and very low levels of CBC, CBN and THC-V (<0.1%). "Known Provenance" samples showed no significant differences in THC content between those seized from indoor versus outdoor cultivation sites. The present analysis echoes trends reported in other countries towards the use of high potency cannabis with very low CBD content. The implications for public health outcomes and harm reduction strategies are discussed.
authors.affiliation: National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia. w.swift@unsw.edu.au
authors.forename: Wendy
authors.initials: W
authors.lastname: Swift
authors.forename: Alex
authors.initials: A
authors.lastname: Wong
authors.forename: Kong M
authors.initials: KM
authors.lastname: Li
authors.forename: Jonathon C
authors.initials: JC
authors.lastname: Arnold
authors.forename: Iain S
authors.initials: IS
authors.lastname: McGregor
mesh_terms: D001315:Australia; D002185:Cannabidiol / Q000032:analysis; D002186:Cannabinoids / Q000032:analysis; D002188:Cannabis / Q000737:chemistry*; D002851:Chromatography, High Pressure Liquid; D010936:Plant Extracts / Q000032:analysis
chemical_list: D002186:Cannabinoids; D010936:Plant Extracts; D002185:Cannabidiol; C010695:cannabichromene
references.citation: Forensic Sci Int. 2012 Sep 10;221(1-3):77-83
references.pmid: 22554871
references.citation: Addiction. 2008 Jul;103(7):1100-9
references.pmid: 18494838
references.citation: Psychopharmacology (Berl). 2011 Nov;218(2):443-57
references.pmid: 21667074
references.citation: Curr Pharm Des. 2012;18(32):5113-30
references.pmid: 22716133
references.citation: Br J Psychiatry. 2010 Oct;197(4):285-90
references.pmid: 20884951
references.citation: J Psychopharmacol. 2013 Jan;27(1):19-27
references.pmid: 23042808
references.citation: Br J Pharmacol. 2011 Aug;163(7):1344-64
references.pmid: 21749363
references.citation: J Forensic Sci. 2008 Jan;53(1):90-4
references.pmid: 18279244
references.citation: Addict Biol. 2005 Jun;10(2):171-80
references.pmid: 16191670
references.citation: Curr Drug Abuse Rev. 2012 Mar;5(1):32-40
references.pmid: 22150622
references.citation: Forensic Sci Int. 2010 Oct 10;202(1-3):36-44
references.pmid: 20462712
references.citation: Addiction. 2010 Jun;105(6):1071-9
references.pmid: 20331568
references.citation: Harm Reduct J. 2005 Oct 04;2:18
references.pmid: 16202145
references.citation: Arch Gen Psychiatry. 2012 Jan;69(1):27-36
references.pmid: 22213786
references.citation: J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Dec 15;877(32):4115-24
references.pmid: 19932642
references.citation: Lancet. 2012 Jan 7;379(9810):55-70
references.pmid: 22225671
references.citation: Br J Pharmacol. 2012 Jun;166(4):1444-60
references.pmid: 22300105
references.citation: Drug Alcohol Depend. 2011 Aug 1;117(1):59-61
references.pmid: 21288662
references.citation: Toxicol Lett. 2012 Nov 15;214(3):314-9
references.pmid: 22963825
references.citation: Chem Biodivers. 2007 Aug;4(8):1649-63
references.pmid: 17712812
references.citation: Br J Pharmacol. 2010 Jan;159(1):129-41
references.pmid: 20002104
references.citation: Forensic Sci Int. 2012 Oct 10;222(1-3):40-6
references.pmid: 22608266
references.citation: Phytomedicine. 2012 Jun 15;19(8-9):819-24
references.pmid: 22571976
references.citation: Int J Drug Policy. 2007 May;18(3):168-76
references.pmid: 17689363
references.citation: Drug Test Anal. 2013 Jan;5(1):62-7
references.pmid: 23169764
references.citation: J Forensic Sci. 2010 Sep;55(5):1209-17
references.pmid: 20487147
references.citation: Br J Pharmacol. 2007 Mar;150(5):586-94
references.pmid: 17245367
references.citation: J Nat Prod. 1980 Mar-Apr;43(2):169-234
references.pmid: 6991645
references.citation: Aust N Z J Psychiatry. 2012 Dec;46(12):1182-92
references.pmid: 22984111
references.citation: Neuropsychopharmacology. 2010 Aug;35(9):1879-85
references.pmid: 20428110
references.citation: Addiction. 2007 Apr;102(4):597-606
references.pmid: 17362293
references.citation: Br J Pharmacol. 2011 Feb;162(3):584-96
references.pmid: 20942863
references.citation: Br J Psychiatry. 2008 Apr;192(4):306-7
references.pmid: 18378995
references.citation: Drug Alcohol Depend. 2003 Jul 20;71(1):37-48
references.pmid: 12821204
references.citation: Br J Psychiatry. 2009 Dec;195(6):488-91
references.pmid: 19949195
references.citation: Forensic Sci Int. 2005 Apr 20;149(1):3-10
references.pmid: 15734104
references.citation: Br J Pharmacol. 2013 May;169(1):213-29
references.pmid: 23373571
references.citation: Addiction. 2005 Jul;100(7):884-6
references.pmid: 15954994
references.citation: J Forensic Sci. 2012 Jul;57(4):918-22
references.pmid: 22390363
references.citation: Br J Pharmacol. 2013 Jun;169(3):685-92
references.pmid: 23488964
references.citation: Schizophr Res. 2011 Aug;130(1-3):216-21
references.pmid: 21592732